What people are asking this week

A manual, static trend board for now. Social and forum signals are treated as claim-demand signals, not evidence or advice.

Peptide regulation

Is BPC-157 actually FDA-approved for injury recovery?

Peptide-compounding review and social recovery claims are colliding.

Bottom line:Not proven

Geroprotector watch

mTOR and geroprotector threads keep driving reader demand.

Bottom line:Promising, not settled

Gene therapy frontier

Biotech announcements make frontier research sound closer to consumers than it is.

Bottom line:Watch the status

Clinic claim

Clinic marketing is converting NAD biology into consumer offers.

Bottom line:Misleading